オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - pizotifen malate, quantity: 0.725 mg - tablet, sugar coated - excipient ingredients: colloidal anhydrous silica; povidone; acacia; purified talc; sucrose; lactose monohydrate; cetyl palmitate; magnesium stearate; maize starch; titanium dioxide - indications as at 14 june 2004: prophylactic (interval) treatment of vascular headaches: typical and atypical migraine, vasomotor headache, cluster headache (horton's syndrome). sandomigran is without effect in the migraine attack. for this purpose preparations containing ergotamine are recommended.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - pizotifen malate 0.725mg equivalent to 0.5 mg pizotifen;  ;   - tablet - 500 mcg - active: pizotifen malate 0.725mg equivalent to 0.5 mg pizotifen     excipient: acacia cetyl palmitate colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch povidone purified talc   sucrose titanium dioxide - indications prophylactic treatment of recurrent vascular headaches, such as · typical or atypical migraine · vasomotor headache · cluster headache (horton's syndrome). sandomigran is less effective in tension headache and in psychogenic and post-traumatic headaches. it is not effective in relieving migraine attacks once in progress.

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - pizotifen maleate - coated tablets - 1.5 milligram

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - pizotifen 1mg - tablet - 1 mg - active: pizotifen 1mg

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - pizotifen maleate - coated tablets - 500 microgram

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - pizotifen hydrogen malate - oral tablet - 1.5mg

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - pizotifen hydrogen malate - oral tablet - 1.5mg

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - donepezil hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; hyprolose; purified talc; microcrystalline cellulose; titanium dioxide; sodium stearylfumarate; macrogol 6000; iron oxide yellow; hypromellose - donepezil is indicated for the treatment of mild, moderate and severe alzheimer's disease.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - donepezil hydrochloride, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; titanium dioxide; hypromellose; maize starch; hyprolose; purified talc; sodium stearylfumarate; macrogol 6000 - donepezil is indicated for the treatment of mild, moderate and severe alzheimer's disease.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - donepezil hydrochloride, quantity: 5 mg (equivalent: donepezil, qty 4.56 mg) - tablet, film coated - excipient ingredients: maize starch; lactose monohydrate; magnesium stearate; microcrystalline cellulose; hyprolose; titanium dioxide; hypromellose; purified talc; macrogol 400 - donepezil hydrochloride is indicated for the treatment of mild, moderate and severe alzheimer?s disease.